Currently, monoclonal antibody drugs are a commonly used immunotherapy in cancer treatment. These drugs may be used in combination with other cancer treatments, such as hormone therapy or chemotherapy. Before deciding to use a monoclonal antibody drug to treat cancer, you need to carefully consider the benefits and potential side effects that the drug may bring.

Currently, the use of monoclonal antibodies is considered an extremely effective cancer treatment method. Monoclonal antibodies can trigger the immune system to attack and destroy cancer cells in the body. However, some monoclonal antibody drugs sometimes cause unwanted side effects for patients.

Brodalumab has been used in trials studying the treatment of Asthma, Psoriasis, Crohn's, Psoriatic Arthritis, and Rheumatoid Arthritis. To ensure safety and maximize the effectiveness of treatment, patients need to take Brodalumab exactly as prescribed by the doctor / pharmacist.

Targeted therapy is cancer therapy by using drugs to limit the growth and spread of cancer, usually applied on patients with advanced cancer, progression and distant metastases that local treatments such as surgery and radiotherapy cannot perform.

Targeted therapy, or more precisely, "molecular targeted therapy," is used to control cancer growth. They act on a specific molecular target inside or on the surface of cancer cells (genes or proteins). This helps to kill or slow down the growth of cancer cells, while minimizing damage to healthy cells.

Breast cancer is a very common disease, in Vietnam, breast cancer ranks first in incidence and third in mortality in women. Breast cancer treatment is a multimodal treatment combining many methods, each stage has different treatment methods to bring the highest treatment effect to the patient.

The World Health Organization (WHO) classification of breast tumors has been published 5 times. In each classification, WHO has rearranged breast adenomas and there are a number of new entities recognized, in the last 2 breast cancer classifications, there are a number of changes including: